Although FTO knockdown inhibits melanoma tumor growth in both immunocompromised and immunocompetent hosts (Figs. 2f, 8a, b), the response of FTO knockdown cells to anti-PD-1 requires host adaptive immunity (Fig. 8a, b). The gene discussed is FTO; the disease is melanoma.